HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 32 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $102,544 | +158.6% | 132,059 | 0.0% | 0.00% | – |
| Q4 2022 | $39,657 | -40.8% | 132,059 | 0.0% | 0.00% | – |
| Q3 2022 | $67,000 | -13.0% | 132,059 | -0.9% | 0.00% | – |
| Q2 2022 | $77,000 | -58.2% | 133,264 | -6.3% | 0.00% | – |
| Q1 2022 | $184,000 | +14.3% | 142,204 | +0.9% | 0.00% | – |
| Q4 2021 | $161,000 | -26.8% | 140,999 | -1.7% | 0.00% | – |
| Q3 2021 | $220,000 | -23.6% | 143,428 | -1.4% | 0.00% | – |
| Q2 2021 | $288,000 | +7.5% | 145,515 | 0.0% | 0.00% | – |
| Q1 2021 | $268,000 | +92.8% | 145,515 | +129.5% | 0.00% | – |
| Q4 2020 | $139,000 | – | 63,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 51,989 | $79,543,000 | 0.24% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 133,500 | $204,000 | 0.10% |
| Ikarian Capital, LLC | 553,273 | $847,000 | 0.06% |
| McAdam, LLC | 55,978 | $86,000 | 0.01% |
| JGP Wealth Management, LLC | 15,000 | $23,000 | 0.01% |
| Prospera Financial Services Inc | 30,300 | $46,000 | 0.00% |
| Fort Point Capital Partners LLC | 10,000 | $15,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 55,599 | $85,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 6,501 | $10,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 49,800 | $76,000 | 0.00% |